Cloud Stock List (Weekly) (Part 2)
○List of Unbroken Stocks Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime <1803> Shimizu Ken 880 995.75 891.5 <1821> Misumi Kensetsu 393 395.75 395 <1893> Goyoken 666 833.5 778 <2002>
Convertible Stock List (Part 2) [Parabolic Signal Convertible Stock List]
○List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime <1780> Yamaura 1369 1412 <1786> Oriental Shiraishi 355 387 <1805> Tobishima Ken 1370 1429 <1812> Kashima 2715 3057 <1833> Okumura Gumi 4840 501
List of Unrivaled Stocks (Part 2) [Ichimoku Equilibrium Chart/Kumoku Stock List]
○List of Unbroken Stocks Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime <1786> Oriental Shiraishi 355 397.5 380 <1803> Shimizu Ken 912 947.5 953 <1812> Kashima 2715 3028.25 2888.5 <1950> Japan
SoftBank G turns 24/3 ordinary profit and loss surplus to 57.8 billion yen
The financial results for the fiscal year ending 2024/3 announced by SoftBank G were sales of 6.756.5 billion yen, up 2.8% from the previous fiscal year, and ordinary profit and loss surplus of 57.81 billion yen (deficit of 469.27 billion yen in the previous fiscal year). The corporate value of investees improved due to global stock appreciation. The yen equivalent amount of US dollar debt increased due to the depreciation of the yen, and exchange losses of 703.1 billion yen were recorded. The investment profit and loss of the SoftBank Vision Fund (SVF) business was in surplus of 724.3 billion yen. [Positive Evaluation] <2587>Sa
Rohto Pharmaceutical FY Net Y30.94B Vs Net Y26.38B
Rohto Pharmaceutical Co. Ltd. (4527.TO) Japan Year Ended March 31 GROUP 2024 2023 Revenue Y270.84 bln Y238.66 bln Operating Profit Y40.05
Rohto Pharmaceutical: Rohto Pharmaceutical Co., Ltd. 88th term (2023) reference materials
Rohto Pharmaceutical: Financial results briefing for the fiscal year ending 2024/3
Rohto Pharmaceutical: Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Pharma F Research Memo (2): Creation of food ingredients with clear functions useful for maintaining health and improving quality of life
■Company Overview 1. Company Overview Pharma Foods <2929> is a biotechnology company aiming for “Pharma Foods” (Pharma Foods) consisting of a fusion of “pharmaceuticals” (pharmaceuticals) and “foods” (Foods), with a basic management policy to contribute to people's health. Using “immunity,” “aging,” and “nerves,” the three elements involved in life activity and health maintenance as development concepts, from familiar ingredients such as eggs, milk, green tea, rice, and lactic acid bacteria to 3 elements
List of Unrivaled Stocks (Part 1) [Ichimoku Equilibrium Chart/Kumoku Stock List]
○Kumagai Stock List Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime <1820> Nishimatsuken 4543 4488.5 4282 <1860> Todaken 1020 1005.25 988.5 <1861> Kumagai Gumi 4130 4102.5 4010 <1934>
Convertible Stock List (Part 1) [Parabolic Signal Convertible Stock List]
○List of purchase-conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime <1766> Token Corpo 10670 10130 <1884> day road 1874 1773 <1925> Daiwa House 4283 4172 <1964 > Chugai furnace 2884 2710 <2060> feed one
Brands that moved the day before part 2 PLANT, Sumiseki HD, Regil, etc.
<コード>Stock name closing price on the 24th ⇒ revised downward to the final major deficit due to Ahresty <5852> 647 -129 impairment recording compared to the previous day. Disgusted with potential dilution due to the issuance of Resonac <4004> 3390 -321CB. Profitable sales from fund shifts in the high price range of Hokkaido Electric Power <9509> 1155.5 -82.5. Orbic <4684> The rate of increase in sales for the fiscal year ending 20035 -16351-3 fell to the 1-digit range. Strike <6196> 4445 -365
List of Yunlou stocks [Ichimoku equilibrium table/ Yunlou stock list]
○Cloud Top Stock List Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime <2002> Nissin Powder G 2104 2100.25 2008.5 <2730> EDION 1592 1544.5 1566.5 <2742> Hello's 4500 4398.75 4275 <2792>
Front market [stocks that have moved, stocks that have been created]
*Onward HD <8016> 638 +67 I like the 2-digit profit and dividend increase forecast for the current fiscal year. *Fuji Oil <5017> 565 +23 continues to be a clue to the rise in crude oil prices. *Hi Day Hidaka <7611> 2720 +84 received the performance improvement observation report and reviewed and bought. *PeptiDream <4587> 1497 +36 There is also a movement to review the forecast for a significant increase in profit for the current fiscal year. *Looking at Kobe Bussan <3038> 3617 +73 depreciation of the yen exchange rate as material. *Suruga Gin
Fuji Electric, Rohto Pharmaceutical, etc. [List of brand materials from newspapers]
*Fuji Electric <6504> power semiconductor module for renewable energy, rated current increased by 80% (Nikkan Kogyo page 1) - ○*Konica Minolta <4902>reduced by 2400 people, leading to sustainable growth through structural reforms (Nikkan Kogyo side 3) - ○*JR Tokai <9022> linear “Yamanashi-ken Station” 31-year construction completion forecast (Nikkan Kogyo page 3) - ○*ube<4208 > invested in AMU for recycling waste fishing nets (Nikkan Kogyo page 3) -○*<45 Pharmaceutical 27>Mitsui & Co., and Singapore Chinese Medicine Acquired for 88 billion yen (daily publication)
Check out the disclosed information for [Tomorrow's Good and Bad Materials]! (Announced on 4/4)
[Good news] ――――――――――■Qushim [Tokyo Stock Exchange S] will record a profit of 35 million yen from the sale of investment securities as special profit for the 2nd quarter of the fiscal year ending 24/10. ■eSupport Link [TSE S] The 12-2 fiscal year (1Q) accounts surged and landed in surplus. ■Adastria [Tokyo Stock Exchange P] Current account increased 3% to the highest profit for the 2nd consecutive term, and dividends for the first fiscal year increased by 5 yen, and dividends for the current fiscal year increased by 5 yen. ■McDonald's Holdings Japan
Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang
By Kosaku Narioka Rohto Pharmaceutical and Mitsui & Co. plan to acquire Singapore-based Chinese herbal medicine company Eu Yan Sang International in a deal that values the company at 800 million Sing
Yunlou Stock List (Weekly Chart) [Ichimoku Equilibrium Chart/Cloud Stock List]
○Cloud Top Stock List Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime <1429> Japan Aqua 1056 987.75 901.5 <1926> Light Engineering 2037 2010.5 1978 <2389> Digital HD 1188 1053 1121 <2492> Info MT
Convertible Stock List (Part 3) [Parabolic Signal Convertible Stock List]
○ List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime <2922> Natori 2114 2179 <2931> Euglena 605 641 <3002> Gunze 5420 5680 <3036> Alconix 1435 1496 <3087> Doutor Day Less
Rohto Pharmaceutical's Profit Climbs 21% in Fiscal Nine Months, Lifts Fiscal-Year Outlook
Rohto Pharmaceutical (TYO:4527) boosted its fiscal-year outlook after posting stronger results for the fiscal nine months as its American operations led the broad-based growth. The over-the-counter dr
No Data